In PCa, ferroptosis has therapeutic potential: PCa cells depend on lipid metabolism, AR signaling regulates ferroptosis defense mechanisms (SLC7A11 and MBOAT2) [18], and novel ferroptosis inducers demonstrate marked preclinical efficacy [18,19]. The gene discussed is AR; the disease is posterior cortical atrophy.